Biotech RadarJobs updated

COMPANY

Neuraly

neuralymed.com ↗

Clinical Phase 2

Keywords: neurology Parkinson's disease Alzheimer's disease NAFLD Type2 Diabetes NASH Parkinson Disease Overweight and Obesity Type 2 Diabetes Mellitus NLY01 DD01

Profile checked Oct 10, 2026

5Trials (company is sponsor)

Timeline

  1. Trial start Phase 2: A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH source ↗
  2. Trial start 1: A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD source ↗
  3. Trial start Phase 2: A Clinical Study of NLY01 in Patient's With Early Parkinson's Disease source ↗
  4. Trial start Phase 2: A Study With NLY01 in Subjects With Type 2 Diabetes source ↗
  5. Trial start 1: A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects source ↗

Clinical trials (lead sponsor) 5

RecordTitlePhaseStatusStartPrimary completion
NCT06410924A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASHPhase 2CompletedJun 13, 2024May 20, 2025 (actual)
NCT04154072A Clinical Study of NLY01 in Patient's With Early Parkinson's DiseasePhase 2CompletedFeb 27, 2020Feb 14, 2023 (actual)
NCT04812262A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD1CompletedFeb 24, 2021Dec 20, 2022 (actual)
NCT04159766A Study With NLY01 in Subjects With Type 2 DiabetesPhase 2CompletedOct 16, 2019Dec 4, 2020 (actual)
NCT03672604A Phase 1 Study to Assess the Safety of NLY01 in Healthy Subjects1CompletedSep 19, 2018Jul 30, 2019 (actual)
Feedback